Anti-infective Agents Market 2020 by Manufacturers, Size, Regions Analysis(Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2025
Published Date: Mar, 2020 | 115 Pages | Report ID: RI_22904
Anti-infective Agents Market 2020 by Manufacturers, Size, Regions Analysis(Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2025 (Updated Report Available)
ID : RI_
22904 | Date :
Mar, 2020 | Pages :
115 | Region : Global |
Publisher : RI
The Anti-infective Agents market had reached xxx million USD with a CAGR xx from 2015-2019. Later on, it will go to xxx million USD in 2020 with a CAGR xx % from 2020 to 2025.
Anti-infective agents are drugs used for the purpose of killing and/or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites. Infections thus caused can be classified depending on type of organism causing the infection and symptoms and medical signs shown by the host.
North America was one of the dominated countries in 2015 with a revenue generation of over USD 26.3 billion. The presence of sophisticated healthcare infrastructure and high awareness amongst the end-users such as clinicians and healthcare professionals in this region are estimated to be the key factors contributing to this large share. Moreover, in this region, the high purchasing power of expensive drugs and the presence of favorablereimbursement policies are the drivers projected to accentuate the growth of the anti-infective agents market.
Asia-Pacific is expected to witness significant growth over the forecast period owing to the presence of generics companies, the rising economic stability, and the increasing level of disposable income. In addition, the growing geriatric population base coupled with the increased susceptibility to infections is expected to provide a potential growth platform to this industry.
In the global Anti-infective Agents market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the market on the basis of application, type, regions, and manufactures.
In global market, the following companies are covered:
Pfizer Inc.
Abbott Laboratories
Gilead Sciences, Inc.
Bristol-Myers Squibb Co.
Merck & Co., Inc.
Bayer Healthcare AG
AstraZeneca Plc.
Boehringer Ingelheim
Novartis AG
Astellas Pharma, Inc.
GlaxoSmithKline Plc.
Alcon Pharmaceuticals Ltd.
Sanofi-Aventis S.A.
Johnson & Johnson
Market Segment by Product Type
Antibacterial Drugs
Antifungal Drugs
Antiviral Drugs
Market Segment by Application
Hospital Use
Clinic Use
Household
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Anti-infective Agents market for the forecast period 2020 - 2025?
• What are the driving forces in the Anti-infective Agents market for the forecast period 2020 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Anti-infective Agents industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Anti-infective Agents Market Size Growth Rate by Type (2019-2025)
1.3.2 Antibacterial Drugs
1.3.3 Antifungal Drugs
1.3.4 Antiviral Drugs
1.4 Market Segment by Application
1.4.1 Global Anti-infective Agents Market Share by Application (2019-2025)
1.4.2 Hospital Use
1.4.3 Clinic Use
1.4.4 Household
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-infective Agents Market Size
2.1.1 Global Anti-infective Agents Revenue 2015-2025
2.1.2 Global Anti-infective Agents Sales 2015-2025
2.2 Anti-infective Agents Growth Rate by Regions
2.2.1 Global Anti-infective Agents Sales by Regions 2015-2019
2.2.2 Global Anti-infective Agents Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Anti-infective Agents Sales by Manufacturers
3.1.1 Anti-infective Agents Sales by Manufacturers 2015-2019
3.1.2 Anti-infective Agents Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Anti-infective Agents Revenue by Manufacturers (2015-2019)
3.2.2 Anti-infective Agents Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Anti-infective Agents Market Concentration Ratio (CR5 and HHI)
3.3 Anti-infective Agents Price by Manufacturers
3.4 Key Manufacturers Anti-infective Agents Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Anti-infective Agents Market
3.6 Key Manufacturers Anti-infective Agents Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Antibacterial Drugs Sales and Revenue (2015-2019)
4.1.2 Antifungal Drugs Sales and Revenue (2015-2019)
4.1.3 Antiviral Drugs Sales and Revenue (2015-2019)
4.2 Global Anti-infective Agents Sales Market Share by Type
4.3 Global Anti-infective Agents Revenue Market Share by Type
4.4 Anti-infective Agents Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Anti-infective Agents Sales by Application
6 United States
6.1 United States Anti-infective Agents Breakdown Data by Company
6.2 United States Anti-infective Agents Breakdown Data by Type
6.3 United States Anti-infective Agents Breakdown Data by Application
7 European Union
7.1 European Union Anti-infective Agents Breakdown Data by Company
7.2 European Union Anti-infective Agents Breakdown Data by Type
7.3 European Union Anti-infective Agents Breakdown Data by Application
8 China
8.1 China Anti-infective Agents Breakdown Data by Company
8.2 China Anti-infective Agents Breakdown Data by Type
8.3 China Anti-infective Agents Breakdown Data by Application
9 Rest of World
9.1 Rest of World Anti-infective Agents Breakdown Data by Company
9.2 Rest of World Anti-infective Agents Breakdown Data by Type
9.3 Rest of World Anti-infective Agents Breakdown Data by Application
9.4 Rest of World Anti-infective Agents Breakdown Data by Countries
9.4.1 Rest of World Anti-infective Agents Sales by Countries
9.4.2 Rest of World Anti-infective Agents Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Pfizer Inc.
10.1.1 Pfizer Inc. Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Anti-infective Agents
10.1.4 Anti-infective Agents Product Introduction
10.1.5 Pfizer Inc. Recent Development
10.2 Abbott Laboratories
10.2.1 Abbott Laboratories Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Anti-infective Agents
10.2.4 Anti-infective Agents Product Introduction
10.2.5 Abbott Laboratories Recent Development
10.3 Gilead Sciences, Inc.
10.3.1 Gilead Sciences, Inc. Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Anti-infective Agents
10.3.4 Anti-infective Agents Product Introduction
10.3.5 Gilead Sciences, Inc. Recent Development
10.4 Bristol-Myers Squibb Co.
10.4.1 Bristol-Myers Squibb Co. Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Anti-infective Agents
10.4.4 Anti-infective Agents Product Introduction
10.4.5 Bristol-Myers Squibb Co. Recent Development
10.5 Merck & Co., Inc.
10.5.1 Merck & Co., Inc. Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Anti-infective Agents
10.5.4 Anti-infective Agents Product Introduction
10.5.5 Merck & Co., Inc. Recent Development
10.6 Bayer Healthcare AG
10.6.1 Bayer Healthcare AG Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Anti-infective Agents
10.6.4 Anti-infective Agents Product Introduction
10.6.5 Bayer Healthcare AG Recent Development
10.7 AstraZeneca Plc.
10.7.1 AstraZeneca Plc. Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Anti-infective Agents
10.7.4 Anti-infective Agents Product Introduction
10.7.5 AstraZeneca Plc. Recent Development
10.8 Boehringer Ingelheim
10.8.1 Boehringer Ingelheim Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Anti-infective Agents
10.8.4 Anti-infective Agents Product Introduction
10.8.5 Boehringer Ingelheim Recent Development
10.9 Novartis AG
10.9.1 Novartis AG Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Anti-infective Agents
10.9.4 Anti-infective Agents Product Introduction
10.9.5 Novartis AG Recent Development
10.10 Astellas Pharma, Inc.
10.10.1 Astellas Pharma, Inc. Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Anti-infective Agents
10.10.4 Anti-infective Agents Product Introduction
10.10.5 Astellas Pharma, Inc. Recent Development
10.11 GlaxoSmithKline Plc.
10.12 Alcon Pharmaceuticals Ltd.
10.13 Sanofi-Aventis S.A.
10.14 Johnson & Johnson
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Anti-infective Agents Sales Channels
11.2.2 Anti-infective Agents Distributors
11.3 Anti-infective Agents Customers
12 Market Forecast
12.1 Global Anti-infective Agents Sales and Revenue Forecast 2019-2025
12.2 Global Anti-infective Agents Sales Forecast by Type
12.3 Global Anti-infective Agents Sales Forecast by Application
12.4 Anti-infective Agents Forecast by Regions
12.4.1 Global Anti-infective Agents Sales Forecast by Regions 2019-2025
12.4.2 Global Anti-infective Agents Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Reports Insights offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Reports Insights assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Reports Insights provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
The report is pretty good as a whole. Especially, the analysis on margin and manufacturing cost is challenging to investigate in general. The team of Reports Insights provided a proper explanation to this. It helped me understand the market well, which leads to our interest in the next marketing report from Reports Insights. I would like to thank the entire team for living up to my expectations in terms of quality & value.
I am completely satisfied with the information given in the report. Report Insights is a value driven company just like us.
Privacy requested , Managing Director
Reports Insights have understood our exact need and Delivered a solution for our requirements. Our experience with them has been fantastic.
Privacy requested, President
Report of Reports Insight has given us the ability to compete with our competitors, every dollar we spend with Reports Insights is worth every penny Reports Insights have given us a robust solution.
